Fidelity Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,590
| Closed | -$138K | – | 5639 |
|
|
2023
Q2 | $138K | Sell |
3,590
-261,170
| -99% | -$6.71M | ﹤0.01% | 3055 |
|
|
2023
Q1 | $6.13M | Sell |
264,760
-42,050
| -14% | -$1M | ﹤0.01% | 2027 |
|
|
2022
Q4 | $8.04M | Sell |
306,810
-22,429
| -7% | -$497K | ﹤0.01% | 1979 |
|
|
2022
Q3 | $6.47M | Sell |
329,239
-25,595
| -7% | -$513K | ﹤0.01% | 2081 |
|
|
2022
Q2 | $6.21M | Sell |
354,834
-214,339
| -38% | -$3.36M | ﹤0.01% | 2167 |
|
|
2022
Q1 | $9.31M | Sell |
569,173
-446,208
| -44% | -$6.07M | ﹤0.01% | 2146 |
|
|
2021
Q4 | $16.6M | Buy |
1,015,381
+140
| +0% | +$1.99K | ﹤0.01% | 1910 |
|
|
2021
Q3 | $13M | Buy |
1,015,241
+236,719
| +30% | +$3.12M | ﹤0.01% | 2016 |
|
|
2021
Q2 | $11M | Sell |
778,522
-87,300
| -10% | -$1.4M | ﹤0.01% | 2073 |
|
|
2021
Q1 | $13.5M | Hold |
865,822
| – | – | ﹤0.01% | 1941 |
|
|
2020
Q4 | $13.7M | Buy |
865,822
+750,001
| +648% | +$11.3M | ﹤0.01% | 1857 |
|
|
2020
Q3 | $1.41M | Buy |
+115,821
| New | +$1.55M | ﹤0.01% | 2367 |
|
|
2020
Q1 | – | Sell |
-200
| Closed | -$1K | – | 4395 |
|
|
2019
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 3707 |
|
|
2019
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 3702 |
|
|
2019
Q2 | $2K | Sell |
200
-166,628
| -100% | -$2.54M | ﹤0.01% | 3563 |
|
|
2019
Q1 | $3.32M | Sell |
166,828
-80
| -0% | -$1.4K | ﹤0.01% | 2189 |
|
|
2018
Q4 | $2.2M | Sell |
166,908
-230,165
| -58% | -$4.6M | ﹤0.01% | 2257 |
|
|
2018
Q3 | $14.6M | Sell |
397,073
-255,705
| -39% | -$8.21M | ﹤0.01% | 1812 |
|
|
2018
Q2 | $22.8M | Buy |
652,778
+70,203
| +12% | +$2.69M | ﹤0.01% | 1657 |
|
|
2018
Q1 | $27.1M | Buy |
582,575
+154,083
| +36% | +$5.64M | ﹤0.01% | 1583 |
|
|
2017
Q4 | $16.1M | Hold |
428,492
| – | – | ﹤0.01% | 1804 |
|
|
2017
Q3 | $22.8M | Sell |
428,492
-11,860
| -3% | -$705K | ﹤0.01% | 1650 |
|
|
2017
Q2 | $25.1M | Sell |
440,352
-50,600
| -10% | -$2.54M | ﹤0.01% | 1584 |
|
|
2017
Q1 | $26.4M | Sell |
490,952
-79,157
| -14% | -$4.47M | ﹤0.01% | 1579 |
|
|
2016
Q4 | $32.5M | Sell |
570,109
-450,794
| -44% | -$27.3M | ﹤0.01% | 1489 |
|
|
2016
Q3 | $63.4M | Sell |
1,020,903
-540
| -0.1% | -$38.2K | 0.01% | 1197 |
|
|
2016
Q2 | $57.8M | Sell |
1,021,443
-73,420
| -7% | -$4.46M | 0.01% | 1213 |
|
|
2016
Q1 | $70.1M | Sell |
1,094,863
-122,249
| -10% | -$9.89M | 0.01% | 1116 |
|
|
2015
Q4 | $171M | Sell |
1,217,112
-480
| -0% | -$65.2K | 0.02% | 717 |
|
|
2015
Q3 | $118M | Buy |
1,217,592
+181,032
| +17% | +$21.6M | 0.02% | 892 |
|
|
2015
Q2 | $157M | Buy |
+1,036,560
| New | +$171M | 0.02% | 817 |
|
Fidelity Investments's KDNY Position: Q3 2023 in Review
Fidelity Investments sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 3,590 shares — an estimated $138K sold.
Fidelity Investments first reported a position in KDNY in Q2 2015 and held it in 31 quarters. The position peaked at $171M in Q4 2015. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Fidelity Investments reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Fidelity Investments sold 3,590 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $138K.
- Fidelity Investments first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 31 quarters.
- Fidelity Investments's Chinook Therapeutics, Inc. Common Stock position peaked at $171M in Q4 2015.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.